A significant association between the increased expression of Notch1 and HER2 in breast cancer suggested that Notch signaling pathway should be a therapeutic target, especially for HER2-positive breast cancers with poor prognosis (Zardawi et al. 2010). This evidence concerns the gene ERBB2 and breast cancer.